J&J Stops Sales of Transvaginal Mesh

Johnson & Johnson (J&J) says it will halt the worldwide sales of some of its transvaginal mesh devices amid a wave of lawsuits filed by women who claim the company’s products caused them to suffer devastating side effects.

The health care giant faces suits filed by 600 women who allege that the devices – meant to relieve pelvic complaints – instead caused them serious injuries.

In a letter filed with the federal judge who presides over the transvaginal mesh litigation, J&J’s Ethicon unit said it asked the U.S. Food and Drug Administration (FDA) for permission to halt the sale of the medical devices, according to Bloomberg. The letter said that the FDA had not responded to the request.

The medical devices to be discontinued are the Prolift, Prolift + M, TVT Secur, and Prosima systems. Ethicon also asked the FDA to allow it to continue selling the Gynecare Gynemesh with new labeling that limits its use, according to Bloomberg.

The company plans to stop sales over the next three to nine months, according to the Wall Street Journal.

If you or a loved one has been harmed by transvaginal mesh or another medical device, contact Sokolove Law for a free legal consultation and to find out if a product liability lawyer may be able to help you. Call us today at 800-581-6358.

Tags: